Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

News on lung volume reduction surgery.

Erich W Russi1, Walter Weder

  • 1Pulmonary Division, University Hospital of Zurich, CH-8091 Zurich, Switzerland. erich.russi@dim.usz.ch

Swiss Medical Weekly
|February 7, 2003
PubMed
Summary

Lung volume reduction surgery (LVRS) offers significant benefits for advanced emphysema patients. This surgical option improves lung function, reduces breathlessness, and enhances quality of life for many, even potentially increasing survival rates.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Prisciandaro et al. Anatomical Versus Non-Anatomical Pulmonary Metastasectomy: European Multicentre Analysis. <i>Cancers</i> 2026, <i>18</i>, 1037.

Cancers·2026
Same author

Anatomical Versus Non-Anatomical Pulmonary Metastasectomy: European Multicentre Analysis.

Cancers·2026
Same author

CD26 as a potential therapeutic target for lung adenocarcinoma.

Frontiers in oncology·2025
Same author

Reply to: "NeoADAURA: Can We Afford to Overlook Objective Response Rates?" and "Is Major Pathologic Response the Best Surrogate End Point for Neoadjuvant Trials?"

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2025
Same author

Low mortality and favourable outcome in lung volume reduction surgery for different emphysema morphologies.

The European respiratory journal·2025
Same author

Expanding Lung Volume Reduction Surgery Indications: Outcomes in Patients Beyond Conventional National Emphysema Treatment Trial Criteria.

Interdisciplinary cardiovascular and thoracic surgery·2025

Area of Science:

  • Pulmonary Medicine
  • Thoracic Surgery
  • Respiratory Disease Research

Background:

  • Lung volume reduction surgery (LVRS) is a recognized treatment for advanced pulmonary emphysema when conservative therapies fail.
  • LVRS has demonstrated improvements in pulmonary function, dyspnea, exercise tolerance, and quality of life for up to four years in approximately 80% of patients.
  • Patient selection is crucial, with improved outcomes observed in those with homogeneous emphysema, excluding individuals with extremely low FEV1 or diffusion capacity.

Purpose of the Study:

  • To evaluate the efficacy and outcomes of Lung Volume Reduction Surgery (LVRS) in patients with advanced pulmonary emphysema.
  • To assess the impact of LVRS on pulmonary function, symptoms, exercise capacity, and survival.
  • To explore the role of LVRS as a palliative intervention and a potential bridge to lung transplantation.

Main Methods:

  • Review of established data on Lung Volume Reduction Surgery (LVRS) for advanced pulmonary emphysema.
  • Analysis of patient outcomes including pulmonary function tests (FEV1, diffusion capacity), symptom scores, and exercise capacity.
  • Examination of perioperative mortality rates and long-term survival data in selected patient cohorts.
  • Consideration of endoscopic LVRS as an emerging investigational approach.

Main Results:

  • LVRS improves pulmonary function, reduces shortness of breath, and enhances exercise capacity and quality of life in approximately 80% of suitable patients for up to four years.
  • Patients with homogeneous pulmonary emphysema show improvement, provided extremely low FEV1 or diffusion capacity are excluded.
  • Perioperative mortality at experienced centers is less than 2% in appropriately selected patients.
  • Current data suggest LVRS may improve five-year survival in COPD patients and can serve as a bridge to lung transplantation for patients under 60.

Conclusions:

  • Lung volume reduction surgery is an effective therapeutic option for carefully selected patients with advanced pulmonary emphysema.
  • LVRS offers significant functional and symptomatic benefits, potentially improving long-term survival and serving as a bridge to transplantation.
  • Endoscopic LVRS represents a novel, investigational approach currently under evaluation.

Related Experiment Videos